Subscribe: Market Wire - Pharmaceuticals and Biotech: Equipment and Supplies
Preview: Market Wire - Pharmaceuticals and Biotech: Equipment and Supplies

Marketwired - Equipment and Supplies

Marketwired - Equipment and Supplies

Last Build Date: Thu, 18 Jan 2018 16:48:27 EST

Copyright: Copyright: (C) Marketwired

Zecotek Increases Non-Brokered Private Placement to $4.9 Million due to Strong Demand

Thu, 18 Jan 2018 16:15:00 EST

VANCOUVER, BC--(Marketwired - January 18, 2018) -

Relevium to Host Webcast to Discuss Previously Announced Blockchain Project

Thu, 18 Jan 2018 15:14:57 EST

MONTREAL, QUEBEC--(Marketwired - Jan. 18, 2018) - Relevium Technologies Inc. (TSX VENTURE:RLV)(OTC PINK:RLLVF)(FRANKFURT:6BX) (the "Company" or "Relevium"), is pleased to announce that it will be hosting a webcast in conjunction with Quantomic LLC to discuss Tagspire, the virtual intelligent e-retail platform and artificial intelligence technology stack.

Vancouver Medical Spa Advocates Allergan's Rewards Program

Wed, 17 Jan 2018 19:37:39 EST

Vancouver medical spa doctor recommends Brilliant Distinctions to clients who want to save on medical aesthetic procedures

Rennova Health's Epic Reference Labs Receives Accreditation From College of American Pathologists

Wed, 17 Jan 2018 09:20:00 EST

WEST PALM BEACH, FL--(Marketwired - January 17, 2018) - Rennova Health, Inc. (OTCQB: RNVA), (OTCQB: RNVAW) ("Rennova" or the "Company"), a vertically integrated provider of industry-leading diagnostics and supportive software solutions to healthcare providers, that opened its first rural hospital in Oneida, Tenn. in August 2017, announces that its flagship Laboratory, EPIC Reference Labs, Inc. (EPIC) has successfully met the Laboratory Accreditation Program Standards for Accreditation from the College of American Pathologists (CAP). EPIC has been operating as a urine toxicology testing laboratory in Riviera Beach, Fla. since 2015.

Leading Leukemia Experts Join Moleculin's Science Advisory Board

Wed, 17 Jan 2018 08:30:00 EST

HOUSTON, TX--(Marketwired - January 17, 2018) - Moleculin Biotech, Inc., (NASDAQ: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company focused on the development of anti-cancer drug candidates, some of which are based on license agreements with The University of Texas System on behalf of the MD Anderson Cancer Center ("MD Anderson"), today announced the expansion of its Science Advisory Board to include Drs. Jorge Cortes and Elihu Estey.

CTD Holdings' European Clinical Trial Adopted by National Institute for Health Research of England

Tue, 16 Jan 2018 08:00:00 EST

Collaboration Will Provide Infrastructure Support to Study

Radient Technologies Inc. Reiterates its Non-Exposure to U.S. Marijuna-Related Activity

Mon, 15 Jan 2018 08:00:00 EST

EDMONTON, ALBERTA--(Marketwired - Jan. 15, 2018) - In response to the January 12, 2018 statement issued by the Canadian Securities Administrators ("CSA") in which the CSA stated it "is considering whether [its] disclosure-based approach for issuers with U.S. marijuana-related activities remains appropriate in light of the rescission of the Cole Memorandum," Radient Technologies Inc. ("Radient" or the "Corporation") (TSX VENTURE:RTI) wishes to reiterate that its business development, operational, and capital markets activity is currently conducted only where its actions are federally legal, and in compliance with all other applicable laws.

Zecotek Increases Non-Brokered Private Placement

Fri, 12 Jan 2018 18:00:00 EST

VANCOUVER, BC--(Marketwired - January 12, 2018) -

EarlySense Percept Wins Best of Baby Tech Award at CES

Thu, 11 Jan 2018 18:00:00 EST

World's First Contact-Free Fertility Tracker Honored as "Audience Favorite"